Metabolic dysfunction-associated steatotic liver disease as a systemic disorder: extrahepatic manifestations and the need for data-driven phenotyping.

Lobanovs S, Jakovenko M, Ivanova J, Nagaiceva J, Čižovs J, Bļizņuks D

Open source

DOI
10.3389/fendo.2026.1873215
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1873215,
  title = {Metabolic dysfunction-associated steatotic liver disease as a systemic disorder: extrahepatic manifestations and the need for data-driven phenotyping.},
  author = {Lobanovs S and Jakovenko M and Ivanova J and Nagaiceva J and Čižovs J and Bļizņuks D},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1873215},
  url = {https://doi.org/10.3389/fendo.2026.1873215}
}

RIS

TY  - JOUR
TI  - Metabolic dysfunction-associated steatotic liver disease as a systemic disorder: extrahepatic manifestations and the need for data-driven phenotyping.
AU  - Lobanovs S
AU  - Jakovenko M
AU  - Ivanova J
AU  - Nagaiceva J
AU  - Čižovs J
AU  - Bļizņuks D
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1873215
UR  - https://doi.org/10.3389/fendo.2026.1873215
ER  - 

APA

S, L., M, J., J, I., J, N., J, Č., & D, B. (2026). Metabolic dysfunction-associated steatotic liver disease as a systemic disorder: extrahepatic manifestations and the need for data-driven phenotyping.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1873215

Source records